Variables | Total (n = 132) | Group I hs CRP (n = 100) | Group II CRP (n = 32) |
Age, years | |||
Mean ± SD | 58.85 ± 11.97 | 57.85 ± 11.65 | 61.97 ± 12.58 |
Range | 30 - 85 | 30 - 85 | 40 - 82 |
Gender | |||
Male | 87 (65.91%) | 67 (67%) | 20 (62.5%) |
Female | 45 (34.09%) | 33 (33%) | 12 (37.5%) |
Male: female ratio | 1.93:1 | 2.03:1 | 1.67:1 |
Smoking | |||
Never | 35 (26.52%) | 28 (28%) | 7 (21.88%) |
Current | 71 (53.79%) | 53 (53%) | 18 (56.25%) |
Ex-smoker | 26 (19.7%) | 19 (19%) | 7 (21.88%) |
Comorbidities | |||
None | 14 (10.61%) | 10 (10%) | 4 (12.5%) |
DM | 93 (70.45%) | 68 (68%) | 25 (78.13%) |
HTN | 68 (51.52%) | 53 (53%) | 15 (46.88%) |
CAD | 26 (19.7%) | 22 (22%) | 4 (12.5%) |
Disease duration, m | |||
Mean ± SD | 16.6 ± 23.33 | 17.14 ± 23.92 | 14.87 ± 21.66 |
Range | 1.0 - 96 | 1.0 - 96 | 1.0 - 72 |
Hospital stay, days | |||
Mean ± SD | 5.14 ± 1.61 | 5.27 ± 1.62 | 4.75 ± 1.55 |
Range | 1.0 - 9.0 | 1.0 - 9.0 | 2.0 - 9.0 |
Cardiac events | |||
None | 81 (61.36%) | 58 (58%) | 23 (71.88%) |
Acute heart failure | 26 (19.7%) | 21 (21%) | 5 (15.63%) |
Arrhythmia | 16 (12.12%) | 12 (12%) | 4 (12.5%) |
Post-MI angina | 10 (7.58%) | 9 (9%) | 1 (3.13%) |
Cardiogenic shock | 10 (7.58%) | 7 (7%) | 3 (9.38%) |
Outcomes | |||
Medical treatment | 85 (64.39%) | 62 (62%) | 23 (71.88%) |
PCI | 36 (27.27%) | 30 (30%) | 6 (18.75%) |
Death | 11 (8.33) | 8 (8%) | 3 (9.38%) |